SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES

Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices

Michaël G. L. Hertog, P.C.H. Hollman, Betty van de Putte · Journal of Agricultural and Food Chemistry · 1993 · 896 citations

Agriculture, Enology, Food Science +13

THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE

Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · Drug Metabolism and Disposition · 2003 · 784 citations

Medicine, Pharmacokinetics, Pharmacology +17

Reactions and significance of cytochrome P-450 enzymes

F. Peter Guengerich · Journal of Biological Chemistry · 1991 · 603 citations · Full text

Life Sciences, Biochemistry, Enzyme Mechanism +16

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

Peter Ferenci, B Dragosics, H. Dittrich et al. · Journal of Hepatology · 1989 · 499 citations

Medicine, Internal Medicine, Pharmacology +8

Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism

Lalitha Iyer, Diana Hall, Sudip Das et al. · Clinical Pharmacology & Therapeutics · 1999 · 353 citations

Veterinary Medicine, Genetics, Molecular Genetics +15